Stocks and InvestingStocks and Investing
Fri, January 14, 2022
Thu, January 13, 2022
Wed, January 12, 2022
Tue, January 11, 2022

Steven Seedhouse Maintained (APLS) at Strong Buy with Decreased Target to $112 on, Jan 11th, 2022


Published on 2024-10-27 19:14:03 - WOPRAI, Steven Seedhouse
  Print publication without navigation


Steven Seedhouse of Raymond James, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $116 to $112 on, Jan 11th, 2022.

Steven has made no other calls on APLS in the last 4 months.



There are 3 other peers that have a rating on APLS. Out of the 3 peers that are also analyzing APLS, 1 agrees with Steven's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Monday, November 29th, 2021


These are the ratings of the 2 analyists that currently disagree with Steven


  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $84 on, Wednesday, December 8th, 2021
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $72 on, Wednesday, November 24th, 2021